Therapeutic Targeting of the Receptor Tyrosine Kinase Met
Authors:
- 31 December 2003
- book chapter
- Published by Springer Nature
- Vol. 119, 121-138
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- The Semaphorin 4D receptor controls invasive growth by coupling with MetNature Cell Biology, 2002
- Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma developmentOncogene, 2001
- Disassociation of Met-Mediated Biological Responses In Vivo: the Natural Hepatocyte Growth Factor/Scatter Factor Splice Variant NK2 Antagonizes Growth but Facilitates MetastasisMolecular and Cellular Biology, 2000
- Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomasOncogene, 2000
- Role of Focal Adhesion Proteins in Signal Transduction and OncogenesisCritical Reviews™ in Oncogenesis, 1997
- The HGF receptor family: unconventional signal transducers for invasive cell growthGenes to Cells, 1996
- Role of oxygen free radicals in cancer developmentEuropean Journal of Cancer, 1996
- In Vivo Activation ofmetTyrosine Kinase by Heterodimeric Hepatocyte Growth Factor Molecule Promotes AngiogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Overexpression of theMET/HGF receptor in ovarian cancerInternational Journal of Cancer, 1994
- Scatter factor is a fibroblast-derived modulator of epithelial cell mobilityNature, 1987